These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 21718055

  • 1. Regioselective synthesis of water-soluble monophosphate derivatives of combretastatin A-1.
    Tanpure RP, Nguyen BL, Strecker TE, Aguirre S, Sharma S, Chaplin DJ, Siim BG, Hamel E, Lippert JW, Pettit GR, Trawick ML, Pinney KG.
    J Nat Prod; 2011 Jul 22; 74(7):1568-74. PubMed ID: 21718055
    [Abstract] [Full Text] [Related]

  • 2. Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1.
    Tanpure RP, Strecker TE, Chaplin DJ, Siim BG, Trawick ML, Pinney KG.
    J Nat Prod; 2010 Jun 25; 73(6):1093-101. PubMed ID: 20496923
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
    Kaffy J, Pontikis R, Florent JC, Monneret C.
    Org Biomol Chem; 2005 Jul 21; 3(14):2657-60. PubMed ID: 15999202
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804
    [Abstract] [Full Text] [Related]

  • 5. Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.
    Pettit GR, Temple C, Narayanan VL, Varma R, Simpson MJ, Boyd MR, Rener GA, Bansal N.
    Anticancer Drug Des; 1995 Jun 15; 10(4):299-309. PubMed ID: 7786396
    [Abstract] [Full Text] [Related]

  • 6. Development of synthetic methodology suitable for the radiosynthesis of combretastatin A-1 (CA1) and its corresponding prodrug CA1P.
    Shirali A, Sriram M, Hall JJ, Nguyen BL, Guddneppanavar R, Hadimani MB, Ackley JF, Siles R, Jelinek CJ, Arthasery P, Brown RC, Murrell VL, McMordie A, Sharma S, Chaplin DJ, Pinney KG.
    J Nat Prod; 2009 Mar 27; 72(3):414-21. PubMed ID: 19161336
    [Abstract] [Full Text] [Related]

  • 7. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
    Pettit GR, Minardi MD, Rosenberg HJ, Hamel E, Bibby MC, Martin SW, Jung MK, Pettit RK, Cuthbertson TJ, Chapuis JC.
    J Nat Prod; 2005 Oct 27; 68(10):1450-8. PubMed ID: 16252907
    [Abstract] [Full Text] [Related]

  • 8. Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphate.
    Kirwan IG, Loadman PM, Swaine DJ, Anthoney DA, Pettit GR, Lippert JW, Shnyder SD, Cooper PA, Bibby MC.
    Clin Cancer Res; 2004 Feb 15; 10(4):1446-53. PubMed ID: 14977848
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and antitumor activity of benzils related to combretastatin A-4.
    Mousset C, Giraud A, Provot O, Hamze A, Bignon J, Liu JM, Thoret S, Dubois J, Brion JD, Alami M.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3266-71. PubMed ID: 18477509
    [Abstract] [Full Text] [Related]

  • 10. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
    Siles R, Ackley JF, Hadimani MB, Hall JJ, Mugabe BE, Guddneppanavar R, Monk KA, Chapuis JC, Pettit GR, Chaplin DJ, Edvardsen K, Trawick ML, Garner CM, Pinney KG.
    J Nat Prod; 2008 Mar 01; 71(3):313-20. PubMed ID: 18303849
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.
    Pettit GR, Rhodes MR, Herald DL, Chaplin DJ, Stratford MR, Hamel E, Pettit RK, Chapuis JC, Oliva D.
    Anticancer Drug Des; 1998 Dec 01; 13(8):981-93. PubMed ID: 10335271
    [Abstract] [Full Text] [Related]

  • 13. Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.
    Winn BA, Devkota L, Kuch B, MacDonough MT, Strecker TE, Wang Y, Shi Z, Gerberich JL, Mondal D, Ramirez AJ, Hamel E, Chaplin DJ, Davis P, Mason RP, Trawick ML, Pinney KG.
    J Nat Prod; 2020 Apr 24; 83(4):937-954. PubMed ID: 32196334
    [Abstract] [Full Text] [Related]

  • 14. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK.
    J Med Chem; 2005 Jun 16; 48(12):4087-99. PubMed ID: 15943482
    [Abstract] [Full Text] [Related]

  • 15. Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.
    Lawrence NJ, Rennison D, Woo M, McGown AT, Hadfield JA.
    Bioorg Med Chem Lett; 2001 Jan 08; 11(1):51-4. PubMed ID: 11140732
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
    Pettit GR, Lippert JW.
    Anticancer Drug Des; 2000 Jun 08; 15(3):203-16. PubMed ID: 11049088
    [Abstract] [Full Text] [Related]

  • 18. A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors.
    Barnes NG, Parker AW, Ahmed Mal Ullah AA, Ragazzon PA, Hadfield JA.
    Bioorg Med Chem; 2020 Oct 01; 28(19):115684. PubMed ID: 32912434
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization.
    Cushman M, Nagarathnam D, Gopal D, Chakraborti AK, Lin CM, Hamel E.
    J Med Chem; 1991 Aug 01; 34(8):2579-88. PubMed ID: 1875350
    [Abstract] [Full Text] [Related]

  • 20. Combretastatin A-4 analogues as antimitotic antitumor agents.
    Nam NH.
    Curr Med Chem; 2003 Sep 01; 10(17):1697-722. PubMed ID: 12871118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.